Citigroup Inc Sarepta Therapeutics, Inc. Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 1,018,922 shares of SRPT stock, worth $19.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,018,922

Previous 210,320 384.46%

Holding current value

$19.2 Million

Previous $3.6 Million 446.0%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$11.93 - $21.97 $9.65 Million - $17.8 Million	808,602 Added 384.46%	1,018,922 $19.6 Million
Q2 2025 Aug 11, 2025	SELL	$17.1 - $63.66 $2.97 Million - $11 Million	-173,507 Reduced 45.2%	210,320 $3.6 Million
Q1 2025 May 12, 2025	BUY	$63.82 - $127.89 $19.8 Million - $39.6 Million	309,732 Added 418.02%	383,827 $24.5 Million
Q4 2024 Feb 12, 2025	BUY	$104.54 - $137.94 $1.81 Million - $2.39 Million	17,335 Added 30.54%	74,095 $9.01 Million
Q3 2024 Nov 12, 2024	BUY	$124.33 - $156.75 $3.06 Million - $3.86 Million	24,594 Added 76.46%	56,760 $7.09 Million

Q2 2024 Aug 12, 2024	SELL	$113.33 - $163.85 $5.45 Million - $7.88 Million	-48,085 Reduced 59.92%	32,166 $5.08 Million
Q1 2024 May 10, 2024	BUY	$93.7 - $141.53 $1.39 Million - $2.1 Million	14,865 Added 22.73%	80,251 $10.4 Million
Q4 2023 Feb 09, 2024	BUY	$67.31 - $124.76 $1.33 Million - $2.46 Million	19,704 Added 43.13%	65,386 $6.31 Million
Q3 2023 Nov 09, 2023	BUY	$102.5 - $123.59 $198,747 - $239,641	1,939 Added 4.43%	45,682 $5.54 Million
Q2 2023 Aug 10, 2023	SELL	$106.4 - $157.19 $3.97 Million - $5.86 Million	-37,277 Reduced 46.01%	43,743 $5.01 Million
Q1 2023 May 11, 2023	BUY	$117.53 - $155.99 $5.23 Million - $6.94 Million	44,517 Added 121.95%	81,020 $11.2 Million
Q4 2022 Feb 09, 2023	SELL	$100.86 - $132.13 $2.95 Million - $3.86 Million	-29,207 Reduced 44.45%	36,503 $4.73 Million
Q3 2022 Nov 10, 2022	SELL	$75.71 - $119.24 $2.24 Million - $3.52 Million	-29,556 Reduced 31.02%	65,710 $7.26 Million
Q2 2022 Aug 10, 2022	BUY	$62.69 - $88.44 $2.79 Million - $3.94 Million	44,525 Added 87.75%	95,266 $7.14 Million
Q1 2022 May 12, 2022	SELL	$63.15 - $90.42 $2.01 Million - $2.87 Million	-31,769 Reduced 38.5%	50,741 $3.96 Million
Q4 2021 Feb 10, 2022	BUY	$77.28 - $99.42 $2.03 Million - $2.62 Million	26,313 Added 46.82%	82,510 $7.43 Million
Q3 2021 Nov 10, 2021	BUY	$65.97 - $92.48 $3.71 Million - $5.2 Million	56,197 New	56,197 $5.2 Million

Others Institutions Holding SRPT

# of Institutions

407

Shares Held

83.7M

Call Options Held

5.27M

Put Options Held

5.94M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.65B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account